Machine Learning News and Research

RSS

Harnessing repetitive DNA for early cancer detection

People with cancer have different amounts of a type of repetitive DNA -; called Alu elements -; than people without cancer.

4 Mar 2024

Scientists take the first step toward early diagnosis of metastasis formation

Metastases are largely responsible for the death rate of patients with solid cancers; the prognosis of cancer patients reduces significantly if metastases are diagnosed.

4 Mar 2024

AI and predictive medicine: Recent advances

The potential of deep learning (DL) in enhancing predictive modeling for omics data analysis.

4 Mar 2024

Microbial signatures linked to immunotherapy response across cancers

The microbiome can identify those who benefit from combination immunotherapy across multiple different cancers, including rare gynecological cancers, biliary tract cancers and melanoma.

1 Mar 2024

Deep learning-based model development to predict critical pediatric events in general wards

A model that predicts critical events in pediatric individuals admitted to the general ward.

29 Feb 2024

New tool unravels the mystery of DNA-RNA interactions in single cells

Cancers begin with abnormal changes in individual cells, and the ability to track the accumulation of mutations at the single-cell level can shed new light on the early stages of the disease. Such knowledge could enable more effective early detection and treatment options for patients as well as more accurate predictions of disease progression.

29 Feb 2024

Machine learning unveils key molecular players and immune signatures in stress cardiomyopathy

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Stress cardiomyopathy (SCM) is a reversible, self-limiting condition that manifests as left ventricular insufficiency.

28 Feb 2024

AI-based technology unlocks secrets of myasthenic-congenital syndromes

An international team of scientists led by ICREA researcher and Director of the Life Sciences Department at the Barcelona Supercomputing Centre - Centro Nacional de Supercomputación (BSC-CNS), Alfonso Valencia, has developed a technology based on artificial intelligence (AI) for the study of minority diseases and has successfully applied it to identify the possible causes of the appearance of what are known as myasthenic-congenital syndromes, a group of rare inherited disorders that limit the ability to move and cause varying degrees of muscle weakness in patients.

28 Feb 2024

AI-based model enhances efficiency of Type II diabetes prevention efforts

Better prevention of Type II diabetes could save both lives and money. The U.S. spends over $730 billion a year -; nearly a third of all health care spending -; on treating preventable diseases like diabetes.

28 Feb 2024

AHA scientific statement: Advances and challenges in AI applications for cardiovascular medicine

Artificial intelligence (AI) may transform cardiovascular medicine. For now, though, many challenges remain, and few AI tools have been proven to improve care, according to a new American Heart Association scientific statement published today in Circulation, the Association's flagship, peer-reviewed journal.

28 Feb 2024

Using machine learning to identify key predictors of mortality in dementia patients

Researchers at the Icahn School of Medicine at Mount Sinai and others have harnessed the power of machine learning to identify key predictors of mortality in dementia patients.

28 Feb 2024

Harnessing artificial intelligence to enhance infectious disease outbreak investigations

A new research review to be given at a pre-congress day for this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) will highlight the potential artificial intelligence (AI) has to improve the speed and accuracy of investigations into infectious disease outbreaks in hospitals, and potentially provide real time information to stop or prevent them.

27 Feb 2024

Gender differences explored: Cardiovascular health variances in women's lifespan

Women's cardiovascular disease risks and outcomes differ throughout the lifespan from those of men, according to a collection of studies devoted to cardiovascular medicine research focused on women of all ages, published today in a special "spotlight" issue of the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

27 Feb 2024

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Amyotrophic Lateral Sclerosis (ALS) is a fatal type of motor neuron disease characterized by progressive degeneration of nerve cells in the spinal cord and brain, resulting in muscle weakness and paralysis that can include the inability to walk and speak, or even swallow and breathe.

27 Feb 2024

Study finds metabolic checkpoint PHGDH as potential target to modulate tumor-associated macrophages

A study by a scientific team from the University of Vienna and the MedUni Vienna, recently published in the top-class journal Cellular & Molecular Immunology, has a promising result from tumor research: The enzyme phosphoglycerate dehydrogenase (PHDGH) acts as a metabolic checkpoint in the function of tumor-associated macrophages (TAMs) and thus on tumor growth.

27 Feb 2024

Optibrium launches a metabolism prediction software platform tailored to DMPK scientists

Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discove.ry

From Optibrium Ltd. 27 Feb 2024

Harnessing multi-omics and AI for atherosclerotic cardiovascular disease management

Despite considerable life-saving progress, cardiovascular diseases (CVDs) remain the leading cause of death globally, claiming an estimated 17.9 million lives each year.

26 Feb 2024

Ultima announces UG 100™ and reveals disruptive cost and accuracy profile to enable the era of the $100 genome and beyond

Today, the Company is also introducing ppmSeqTM, a disruptive new mode for extreme raw read accuracy in calling single nucleotide variants (SNVs). ppmSeqTM is a new proprietary feature enabled by Ultima’s unique approach that dramatically improves the raw read accuracy of calling SNVs by removing sample errors introduced upstream of the sequencing workflow.

From Ultima Genomics, Inc. 26 Feb 2024

Streamlining AI for precise medical summarization

Medical summarization, a process that uses artificial intelligence (AI) to condense complex patient information, is currently used in health care settings for tasks such as creating electronic health records and simplifying medical text for insurance claims processing.

23 Feb 2024

LabVantage Solutions Introduces Digital Native Ecosystem for R&D Success

With solutions to decrease redundant experiments, improve design of experiments, derive greater insights from data, and automate laboratory workflows, LabVantage Solutions equips R&D labs for success in innovation. Introducing a digital native ecosystem for R&D, LabVantage addresses researchers’ needs in three broad categories of semantic search, analytics, and automation.

From LabVantage Solutions 22 Feb 2024

Machine Learning News and Research

Harnessing repetitive DNA for early cancer detection

Scientists take the first step toward early diagnosis of metastasis formation

AI and predictive medicine: Recent advances

Microbial signatures linked to immunotherapy response across cancers

Deep learning-based model development to predict critical pediatric events in general wards

New tool unravels the mystery of DNA-RNA interactions in single cells

Machine learning unveils key molecular players and immune signatures in stress cardiomyopathy

AI-based technology unlocks secrets of myasthenic-congenital syndromes

AI-based model enhances efficiency of Type II diabetes prevention efforts

AHA scientific statement: Advances and challenges in AI applications for cardiovascular medicine

Using machine learning to identify key predictors of mortality in dementia patients

Harnessing artificial intelligence to enhance infectious disease outbreak investigations

Gender differences explored: Cardiovascular health variances in women's lifespan

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Study finds metabolic checkpoint PHGDH as potential target to modulate tumor-associated macrophages

Optibrium launches a metabolism prediction software platform tailored to DMPK scientists

Harnessing multi-omics and AI for atherosclerotic cardiovascular disease management

Ultima announces UG 100™ and reveals disruptive cost and accuracy profile to enable the era of the $100 genome and beyond

Streamlining AI for precise medical summarization

LabVantage Solutions Introduces Digital Native Ecosystem for R&D Success

AI In Healthcare eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News